samedan logo
 
 
spacer
home > pmps
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

 

Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision-makers within the industry, identifying new trends and marketing opportunities as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharmaceutical, biotech, nutritional and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market.




 
For further information please contact:

Advertising
Jonathan Smith

Editorial
Katharine Marsh

We're also on Twitter! Follow us @PMPSmag  

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.


Click here to view the digital version of PMPS

 


  Click here to view the PMPS Parenteral Technology Supplement   
 

pmps
 
 
Featured in this issue
Cool Chain, Cargo & Logistics
Strategic Partnerships

The Extra Mile

Kamaljit Hunjam
at CEVA Logistics reviews the relationship between a pharma company and its logistics provider. As one of the key links in the supply chain, this affiliation should grow and develop to serve both parties in old and new markets.
Packaging, Packing and Anti-Counterfeiting
Electronic Packaging

A Smart Approach


The Internet of Things technology is continuously advancing – but how can the packaging sector leverage such innovation? Roosje Watson at the Centre for Process Innovation uncovers the benefits of this combination for the manufacturer, supply chain and, ultimately, the consumer.
  Manufacturing
Micronisation

Thinking Small

Elanor Pinto-Cocozza
at Catalent Pharma Solutions discusses a problem that needs to be addressed: the number of drugs that are poorly soluble and permeable in the market. She argues that the answer could be micronisation, with benefits ranging from manufacturing right through to patient compliance.

spacer
Edited by
Robert Harris
Chief Technical Officer at Juniper Pharma Services
Published quarterly in
February, May,
August and November


 

Industry Events

Outsourcing in Clinical Trials West Coast 2017

22-23 February 2017, Hyatt Regency San Francisco Airport Hotel, 1333 Bayshore Highway, Burlingame, 94010

The flagship Outsourcing in Clinical Trials event on the West Coast returns to Burlingame on February 22-23 2017. The must-attend event will bring together over 700 clinical professionals from the Bay Area and beyond, to discuss clinical outsourcing strategies and overcome key challenges within clinical operations.
More info >>

 
News and Press Releases

MasterControl Releases Version 11.6, Upgrades World-Class Quality Management System

MasterControl, a leading global provider of enterprise quality management systems (EQMS) and quality and compliance consulting services, today announced the release of MasterControl Version 11.6, which includes several upgrades designed to enhance the user experience and provide a more streamlined approach to quality management.
More info >>

air transport logo

 

White Papers

Unmet Medical Needs? Impacted by unmet Life Sciences Staffing Needs?

Clinical Professionals

Whilst the majority of Clinical Professionals clients are working to discover and develop innovative, cost effective medicines that address unmet medical needs they are not impacting the unmet needs of training and developing new recruits into the pharma industry. The impact is highlighted within entry level Clinical Trial Administrators and Clinical Research Associates (CTA/CRA). In the past the Pharmaceutical industry had highly developed training programs for these sought after candidates. As the use of outsourcing models and CRO’s has increased and fewer Pharma businesses embark on their own R&D a substantial gap is developing in newly trained Life Science graduates entering the market to commence a career within R&D. As further financial cuts are made within R&D spend this already dire situation continues to escalate.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement